WSTAM
GILD icon

Wilbanks Smith & Thomas Asset Management’s Gilead Sciences GILD Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,653
Closed -$338K – 521
2021
Q4 		$338K Hold
4,653
– – 0.01% 389
2021
Q3 		$325K Hold
4,653
– – 0.01% 372
2021
Q2 		$320K Sell
4,653
-143
-3% -$9.55K 0.01% 381
2021
Q1 		$310K Buy
+4,796
New +$309K 0.01% 362
2018
Q4 		– Sell
-2,801
Closed -$217K – 721
2018
Q3 		$217K Buy
+2,801
New +$212K 0.01% 377
2018
Q2 		– Sell
-3,457
Closed -$261K – 353
2018
Q1 		$261K Buy
+3,457
New +$275K 0.02% 284
2017
Q4 		– Sell
-3,499
Closed -$283K – 350
2017
Q3 		$283K Buy
3,499
+26
+0.7% +$1.99K 0.02% 257
2017
Q2 		$246K Sell
3,473
-300
-8% -$20K 0.02% 273
2017
Q1 		$256K Sell
3,773
-2,707
-42% -$190K 0.02% 270
2016
Q4 		$464K Sell
6,480
-22,251
-77% -$1.65M 0.04% 173
2016
Q3 		$2.27M Sell
28,731
-491
-2% -$39.9K 0.21% 81
2016
Q2 		$2.44M Buy
29,222
+605
+2% +$53.7K 0.25% 74
2016
Q1 		$2.63M Buy
28,617
+202
+0.7% +$18.2K 0.32% 64
2015
Q4 		$2.88M Sell
28,415
-140
-0.5% -$14.6K 0.28% 57
2015
Q3 		$2.8M Buy
28,555
+198
+0.7% +$22K 0.4% 50
2015
Q2 		$3.32M Sell
28,357
-1,976
-7% -$216K 0.33% 46
2015
Q1 		$2.98M Sell
30,333
-702
-2% -$71.3K 0.29% 60
2014
Q4 		$2.92M Sell
31,035
-2,317
-7% -$240K 0.3% 61
2014
Q3 		$3.55M Sell
33,352
-2,754
-8% -$270K 0.39% 45
2014
Q2 		$2.99M Buy
36,106
+258
+0.7% +$20.1K 0.32% 54
2014
Q1 		$2.54M Buy
35,848
+1,146
+3% +$89.9K 0.29% 60
2013
Q4 		$2.61M Buy
34,702
+1,615
+5% +$112K 0.31% 57
2013
Q3 		$2.08M Buy
33,087
+889
+3% +$53.1K 0.28% 64
2013
Q2 		$1.65M Buy
+32,198
New +$1.68M 0.25% 74

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's GILD Position: Q1 2022 in Review

Wilbanks Smith & Thomas Asset Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 4,653 shares — an estimated $338K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $3.55M in Q3 2014. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 4,653 Gilead Sciences shares in Q1 2022, an estimated $338K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
  • Wilbanks Smith & Thomas Asset Management's Gilead Sciences position peaked at $3.55M in Q3 2014.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2022, filed 5 May 2022.